TipRanksStock Market NewsGDRX NewsSVB Securities Sticks to Its Hold Rating for GoodRx Holdings (GDRX)

SVB Securities Sticks to Its Hold Rating for GoodRx Holdings (GDRX)

In a report released today, Stephanie Davis from SVB Securities maintained a Hold rating on GoodRx Holdings (GDRXResearch Report), with a price target of $11.00. The company’s shares closed yesterday at $7.76.

According to TipRanks, Davis is an analyst with an average return of -0.7% and a 50.48% success rate. Davis covers the Technology sector, focusing on stocks such as NextGen Healthcare, Tabula Rasa HealthCare, and GoodRx Holdings.

In addition to SVB Securities, GoodRx Holdings also received a Hold from Credit Suisse’s Jonathan Yong in a report issued today. However, on the same day, Barclays maintained a Buy rating on GoodRx Holdings (NASDAQ: GDRX).

See the top stocks recommended by analysts >>

The company has a one-year high of $48.05 and a one-year low of $5.62. Currently, GoodRx Holdings has an average volume of 2.27M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.

Read More on GDRX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More